Literature DB >> 27529184

Biosensing Vibrio cholerae with Genetically Engineered Escherichia coli.

Maciej B Holowko1, Huijuan Wang1, Premkumar Jayaraman1, Chueh Loo Poh1.   

Abstract

Cholera is a potentially mortal, infectious disease caused by Vibrio cholerae bacterium. Current treatment methods of cholera still have limitations. Beneficial microbes that could sense and kill the V. cholerae could offer potential alternative to preventing and treating cholera. However, such V. cholerae targeting microbe is still not available. This microbe requires a sensing system to be able to detect the presence of V. cholera bacterium. To this end, we designed and created a synthetic genetic sensing system using nonpathogenic Escherichia coli as the host. To achieve the system, we have moved proteins used by V. cholerae for quorum sensing into E. coli. These sensor proteins have been further layered with a genetic inverter based on CRISPRi technology. Our design process was aided by computer models simulating in vivo behavior of the system. Our sensor shows high sensitivity to presence of V. cholerae supernatant with tight control of expression of output GFP protein.

Entities:  

Keywords:  CRISPRi; Vibrio cholerae; biosensor; cholera; synthetic biology

Mesh:

Substances:

Year:  2016        PMID: 27529184     DOI: 10.1021/acssynbio.6b00079

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  10 in total

1.  Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47.

Authors:  Jacob D Palmer; Emma Piattelli; Beth A McCormick; Mark W Silby; Christopher J Brigham; Vanni Bucci
Journal:  ACS Infect Dis       Date:  2017-09-20       Impact factor: 5.084

Review 2.  Synthetic Biology Tools for Engineering Microbial Cells to Fight Superbugs.

Authors:  Angel León-Buitimea; Francisco de Jesús Balderas-Cisneros; César Rodolfo Garza-Cárdenas; Javier Alberto Garza-Cervantes; José Rubén Morones-Ramírez
Journal:  Front Bioeng Biotechnol       Date:  2022-05-04

Review 3.  Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases.

Authors:  Karla Cristina P Cruz; Laura O Enekegho; David T Stuart
Journal:  Front Bioeng Biotechnol       Date:  2022-05-17

4.  Engineered dCas9 with reduced toxicity in bacteria: implications for genetic circuit design.

Authors:  Shuyi Zhang; Christopher A Voigt
Journal:  Nucleic Acids Res       Date:  2018-11-16       Impact factor: 16.971

Review 5.  Synthetic Biology Approaches in The Development of Engineered Therapeutic Microbes.

Authors:  Minjeong Kang; Donghui Choe; Kangsan Kim; Byung-Kwan Cho; Suhyung Cho
Journal:  Int J Mol Sci       Date:  2020-11-19       Impact factor: 5.923

Review 6.  Combating Infectious Diseases with Synthetic Biology.

Authors:  Anooshay Khan; Julian Ostaku; Ebru Aras; Urartu Ozgur Safak Seker
Journal:  ACS Synth Biol       Date:  2022-01-25       Impact factor: 5.110

Review 7.  Microbiome therapeutics: exploring the present scenario and challenges.

Authors:  Monika Yadav; Nar Singh Chauhan
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-11-15

Review 8.  Crosstalks Between Gut Microbiota and Vibrio Cholerae.

Authors:  Zixin Qin; Xiaoman Yang; Guozhong Chen; Chaiwoo Park; Zhi Liu
Journal:  Front Cell Infect Microbiol       Date:  2020-10-23       Impact factor: 5.293

9.  Probiotic strains detect and suppress cholera in mice.

Authors:  Ning Mao; Andres Cubillos-Ruiz; D Ewen Cameron; James J Collins
Journal:  Sci Transl Med       Date:  2018-06-13       Impact factor: 17.956

Review 10.  Theranostic cells: emerging clinical applications of synthetic biology.

Authors:  Monica P McNerney; Kailyn E Doiron; Tai L Ng; Timothy Z Chang; Pamela A Silver
Journal:  Nat Rev Genet       Date:  2021-07-07       Impact factor: 53.242

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.